Blueberries Medical Corp
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0161
- Today's High:
- $0.021
- Open Price:
- $0.021
- 52W Low:
- $0.0092
- 52W High:
- $0.0366
- Prev. Close:
- $0.0185
- Volume:
- 58869
Company Statistics
- Market Cap.:
- $2.44 million
- Book Value:
- 0.005
- Revenue TTM:
- $279628
- Operating Margin TTM:
- -516.28%
- Gross Profit TTM:
- $-17720
- Profit Margin:
- 0%
- Return on Assets TTM:
- -29.31%
- Return on Equity TTM:
- -125.94%
Company Profile
Blueberries Medical Corp had its IPO on under the ticker symbol BBRRF.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Blueberries Medical Corp has a staff strength of 0 employees.
Stock update
Shares of Blueberries Medical Corp opened at $0.02 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.02 - $0.02, and closed at $0.02.
This is a -12.97% slip from the previous day's closing price.
A total volume of 58,869 shares were traded at the close of the day’s session.
In the last one week, shares of Blueberries Medical Corp have slipped by -19.5%.
Blueberries Medical Corp's Key Ratios
Blueberries Medical Corp has a market cap of $2.44 million, indicating a price to book ratio of 132.0668 and a price to sales ratio of 23.7226.
In the last 12-months Blueberries Medical Corp’s revenue was $279628 with a gross profit of $-17720 and an EBITDA of $-1222685. The EBITDA ratio measures Blueberries Medical Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Blueberries Medical Corp’s operating margin was -516.28% while its return on assets stood at -29.31% with a return of equity of -125.94%.
In Q1, Blueberries Medical Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 131%.
Blueberries Medical Corp’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.01 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Blueberries Medical Corp’s profitability.
Blueberries Medical Corp stock is trading at a EV to sales ratio of 27.1785 and a EV to EBITDA ratio of -0.8619. Its price to sales ratio in the trailing 12-months stood at 23.7226.
Blueberries Medical Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $3.05 million
- Total Liabilities
- $1.83 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $2834
- Dividend Payout Ratio
- 0%
Blueberries Medical Corp ended 2024 with $3.05 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.05 million while shareholder equity stood at $1.08 million.
Blueberries Medical Corp ended 2024 with $0 in deferred long-term liabilities, $1.83 million in other current liabilities, in common stock, $-23319008.00 in retained earnings and $0 in goodwill. Its cash balance stood at $907273.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Blueberries Medical Corp’s total current assets stands at $1.85 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $86263.00 compared to accounts payable of $0 and inventory worth $60872.00.
In 2024, Blueberries Medical Corp's operating cash flow was $0 while its capital expenditure stood at $2834.
Comparatively, Blueberries Medical Corp paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.02
- 52-Week High
- $0.0366
- 52-Week Low
- $0.0092
- Analyst Target Price
- $
Blueberries Medical Corp stock is currently trading at $0.02 per share. It touched a 52-week high of $0.0366 and a 52-week low of $0.0366. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.02 and 200-day moving average was $0.02 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6853.3% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Blueberries Medical Corp
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. It produces psychoactive and non-psychoactive cannabis by-products. Blueberries Medical Corp. is based in Vancouver, Canada.